Akcea Therapeutics, Inc. Operating Lease Right-of-Use Assets
Akcea Therapeutics, Inc. had Operating Lease Right-of-Use Assets of $10.65 million as of 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2020-08-05
- 2020-06-30: Operating Lease, Right-of-Use Asset $10.65M.
- 2020-03-31: Operating Lease, Right-of-Use Asset $10.87M.
- 2019-12-31: Operating Lease, Right-of-Use Asset $11.09M.
- 2019-09-30: Operating Lease, Right-of-Use Asset $11.30M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2020-06-30 | $10.65M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $10.87M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $11.09M 10-Q · filed 2020-08-05 |
| 2019-09-30 | $11.30M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $11.53M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $11.60M 10-Q · filed 2019-05-09 |